Paysign, Inc. (PAYS) Reports In-Line Q4 EPS, Offers FY Guidance

Paysign, Inc. (NASDAQ: PAYS) reported Q4 EPS of $0.00, in-line with the analyst estimate of $0.00. Revenue for the quarter came in at $8.8 million versus the consensus estimate of $9 million.

GUIDANCE:

Paysign, Inc. sees FY2022 revenue of $35.25-38.35 million, versus the consensus of $39.62 million.

• “We had another good quarter with revenues, income from operations, EBITDA and adjusted EBITDA all improving both sequentially and year over year. Additionally, our balance sheet improved sequentially as a result of this quarter’s performance. While we continue to see the residual effects of the pandemic on our business, we did see improving transactional trends and a more normal seasonal pattern as we moved through the quarter. We continue to believe that our business will continue to grow and improve in 2022,” said Jeff Baker, Paysign CFO.
• “For the full year 2022, we expect total revenue to be in the range of $35.25 million to $38.35 million, reflecting growth of 20% to 30%, with plasma making up approximately 90% of total revenue. Pharma revenue is expected to be relatively flat year over year as the loss of programs and settlement income in 2021 are offset with new pharma copay programs. Adjusted EBITDA is expected to at least double to $4.0 million over 2021’s adjusted EBITDA of $2.0 million. Full year gross profit margins are expected to be approximately 50.0% to 52.5%, with Q1 2022 gross profit margin expected to be approximately 60% before returning to a more normalized gross profit margin experienced in 2021. We expect this will result in Q1 2022 operating results to be somewhat skewed relative to historical Q1 results. Operating expenses are expected to increase to approximately $20.0 million as we continue to make investments in people and technology, and experience higher costs in insurance, travel and entertainment and other inflationary pressures. Depreciation and amortization is expected to be between $3.0 million and $3.25 million while stock-based compensation is expected to be approximately $2.0 million,” Baker concluded.

For earnings history and earnings-related data on Paysign, Inc. (PAYS) click here.

You May Also Be Interested In

• Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
• Retail investors largely unaware of SEC semiannual reporting proposal
• Radoff-Jumana Group calls for Genesco CEO to lose board chair role